90 related articles for article (PubMed ID: 18448273)
1. Estimation of optimal brachytherapy utilization rate in the treatment of malignancies of the uterine corpus by a review of clinical practice guidelines and the primary evidence.
Thompson SR; Delaney G; Gabriel GS; Jacob S; Das P; Barton M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):849-58. PubMed ID: 18448273
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma of the uterine cervix: review of clinical practice guidelines and primary evidence.
Thompson S; Delaney G; Gabriel GS; Jacob S; Das P; Barton M
Cancer; 2006 Dec; 107(12):2932-41. PubMed ID: 17109449
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the optimal brachytherapy utilization rate in the treatment of gynecological cancers and comparison with patterns of care.
Thompson SR; Delaney GP; Gabriel GS; Jacob S; Das P; Barton MB
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):400-5. PubMed ID: 22658439
[TBL] [Abstract][Full Text] [Related]
4. Estimation of the optimal brachytherapy utilisation rate in the treatment of vaginal cancer and comparison with patterns of care.
Thompson SR; Delaney GP; Gabriel GS; Jacob S; Barton MB
J Med Imaging Radiat Oncol; 2012 Aug; 56(4):483-9. PubMed ID: 22883660
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines.
Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB
Radiother Oncol; 2016 Jan; 118(1):118-21. PubMed ID: 26776443
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care study of brachytherapy in New South Wales: malignancies of the uterine corpus.
Thompson SR; Delaney GP; Gabriel GS; Barton MB
J Contemp Brachytherapy; 2015 Jun; 7(3):224-30. PubMed ID: 26207111
[TBL] [Abstract][Full Text] [Related]
7. Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelines.
Delaney G; Jacob S; Barton M
Cancer; 2006 Jan; 106(2):453-65. PubMed ID: 16355366
[TBL] [Abstract][Full Text] [Related]
8. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.
Delaney G; Barton M; Jacob S
Cancer; 2004 Aug; 101(4):657-70. PubMed ID: 15305395
[TBL] [Abstract][Full Text] [Related]
9. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
[TBL] [Abstract][Full Text] [Related]
10. Dose to the non-involved uterine corpus with MRI guided brachytherapy in locally advanced cervical cancer.
Sapru S; Mohamed S; Fokdal L; Nkiwane K; Swamidas J; Mahantshetty U; Kirisits C; Pötter R; Christian Lindegaard J; Tanderup K
Radiother Oncol; 2013 Apr; 107(1):93-8. PubMed ID: 23490270
[TBL] [Abstract][Full Text] [Related]
11. Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence.
Delaney G; Barton M; Jacob S
Cancer; 2004 Mar; 100(6):1293-301. PubMed ID: 15022299
[TBL] [Abstract][Full Text] [Related]
12. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I--malignancies of the cervix, ovary, vagina and vulva.
Delaney G; Jacob S; Barton M
Cancer; 2004 Aug; 101(4):671-81. PubMed ID: 15305396
[TBL] [Abstract][Full Text] [Related]
13. Image-guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey.
Pavamani S; D'Souza DP; Portelance L; Craighead PS; Pearce AG; Traptow LL; Doll CM
Brachytherapy; 2011; 10(5):345-51. PubMed ID: 21345744
[TBL] [Abstract][Full Text] [Related]
14. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II--carcinoma of the endometrium.
Delaney G; Jacob S; Barton M
Cancer; 2004 Aug; 101(4):682-92. PubMed ID: 15305397
[TBL] [Abstract][Full Text] [Related]
15. [Gamma-glutamyltransferase (EC 2.3.2.2) activity in the course of brachytherapy of the uterine cervix and corpus carcinoma].
Karmowski A; Sobiech KA; Pawelec M; Pałczyński B; Terpiłowski L; Michalik T
Ginekol Pol; 1998 May; 69(5):221-5. PubMed ID: 9695316
[TBL] [Abstract][Full Text] [Related]
16. A systematic overview of radiation therapy effects in uterine cancer (corpus uteri).
Einhorn N; Tropé C; Ridderheim M; Boman K; Sorbe B; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):557-61. PubMed ID: 14596513
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix carcinoma.
Varveris H; Kachris S; Mazonakis M; Lyraraki E; Petineli E; Varveris A; Fasoulaki A; Tzedakis A; Kouloulias V; Zolindaki A; Vlachaki M
Strahlenther Onkol; 2006 Mar; 182(3):125-34. PubMed ID: 16520906
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
[TBL] [Abstract][Full Text] [Related]
19. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
